Patent №
US 8,092,662
Granted
2012-01-10
Filed 2009
Owner
THERASENSE, INC.
+1 more
Lab
—
AI components
2
nlp · vision
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
12371504
Novel transition metal complexes of iron, cobalt, ruthenium, osmium, and vanadium are described. The transition metal complexes can be used as redox mediators in enzyme based electrochemical sensors. In such instances, transition metal complexes accept electrons from, or transfer electrons to, enzymes at a high rate and also exchange electrons rapidly with the sensor. The transition metal complexes include at least one substituted or unsubstituted biimidazole ligand and may further include a second substituted or unsubstituted biimidazole ligand or a substituted or unsubstituted bipyridine or pyridylimidazole ligand. Transition metal complexes attached to polymeric backbones are also described.
AI classification
Ownership
THERASENSE, INC.
assignment · 224700611
ABBOTT DIABETES CARE INC.
namechg · 225170525
Assignors
MAO, FEI, HELLER, ADAM
On an employer assignment, the assignors are typically the inventors.